Central nervous system comorbidities have been identified in patients with epilepsy. Several of these comorbidities have been correlated with poor surgery outcomes in patient cohorts. The authors sought to determine if prevalence of comorbidities in pediatric epilepsy surgery patients and their families correlate with long-term seizure outcome in a cross-sectional analysis. Three-generation pedigrees were elicited to compare family history of epilepsy, ADHD, anxiety, autism, bipolar disorder, cognitive disability, depression, migraine, and motor disability to surgery outcomes in 52 patients. Proportions of affected patients and relatives were compared to general population comorbidity rates and the patients' most recent seizure outcome classification. Patients and families had significantly higher rates of comorbidities than the general population. Poorer long-term seizure outcomes following resective surgery were associated with autism or cognitive disability in patients. Together these data support evidence for a common pathophysiological mechanism between epilepsy and central nervous system comorbidities.
Patients with epilepsy have higher rates of comorbid central nervous system conditions compared to the general population, including attention-deficit/hyperactivity disorder (ADHD), [1] [2] [3] anxiety disorder, [2] [3] [4] autism spectrum disorder, 2,3,5-7 bipolar disorder, 2, 4, 8 cognitive disability, 3, 6, 9 depression, 2-4 migraine, 2, 3, 10 and motor disability, 6, 9 supporting the argument for a shared pathophysiological mechanism. 10, 11 Family history of seizures has previously been associated with the presence of behavioral disorders 11 and migraines 12 in epilepsy patients, suggesting these comorbidities are heritable with epilepsy. However, studies to document whether or not there is also a higher prevalence of these comorbidities in patients' family members are lacking. While worse seizure outcomes following temporal lobectomy have been reported in adult patients with a personal history of psychiatric disorders 13 and pediatric patients with cognitive dysfunction or learning disability 14 and the Childhood Behavior Checklist has been used to report on the rates of behavioral, emotional, and social function in pediatric patients before and after epilepsy surgery, [15] [16] [17] little is known about the relationship between patient and family member central nervous system comorbidities and seizure outcome after epilepsy surgery. As there is no published literature describing the relationship between a family history of central nervous system comorbidities and resective surgery outcomes, the identification of such a relationship would suggest that family history may modify individual prognosis.
The primary aim of this study was to determine prevalence of central nervous system comorbidities (ADHD, anxiety disorder, autism spectrum disorder, bipolar disorder, cognitive disability, depression, migraine, motor disability) in pediatric patients undergoing epilepsy surgery at a single institution and their families, and correlate these findings with long-term seizure outcome. Identification of a correlation between patient comorbidities and their clinical outcomes will strengthen the evidence for a shared pathophysiological mechanism and further aid clinicians in tailoring prognostic predictions prior to surgery.
Methods Cohort
This retrospective cross-sectional study compared family history of epilepsy and central nervous system comorbidities to surgery outcomes in pediatric patients who underwent resective brain surgery. Patients were identified through a clinical seizure database maintained by the CCHMC Division of Neurology. Patients qualified for surgery if they had failed to maintain good seizure control after at least 2 appropriately selected and trialed antiepileptic drugs and a localized seizure focus was identified. All patients who underwent resective surgery for epilepsy, including hemispherectomy, lobectomy, and/or corticectomy, at CCHMC between January 1, 2007, and June 30, 2012, were contacted. Patients who underwent corpus callosotomy only or were over the age of 18 at time of initial surgery were excluded.
Family History Information
Family history information was collected via questionnaire from the patients' parents or legal guardians, referred to as the ''participants.'' Participants who were not able to recount family history information or who did not speak English were excluded.
Familial relationships were labeled in reference to the patient who received resective surgery. An online questionnaire was developed to collect family history information using the Research Electronic Database Capture program. Participants had the option to take the questionnaire online or via telephone. A brief follow-up telephone interview was conducted with online participants. The researcher was blind to patient surgery outcomes at the time of questionnaire completion.
A 3-generation pedigree was obtained. Participants were asked if each family member had been diagnosed by a medical provider with epilepsy, seizures not diagnosed as epilepsy, and central nervous system comorbidities including ADHD, anxiety disorder, autism spectrum disorder, bipolar disorder, cognitive disability, depression, migraine, and motor disability. Comorbidities were defined for participants as stated in Table 1 . Comorbidities reported in the patient were verified in the electronic medical record as occurring presurgery or postsurgery. Comorbidities diagnosed postsurgery were recoded as negative. Demographic information was also collected.
The proportion of affected individuals was calculated by the following formula: (# affected individuals) / (total # individuals). Proportions of affected patients, first-degree relatives, and total relatives were calculated for each comorbidity. First-degree relatives included the patient's parents and full siblings. Total relatives included the patient's first-degree relatives, half siblings, nieces, nephews, grandparents, aunts, uncles, and first cousins.
A history of epilepsy or seizures in family members was collapsed into a single variable, ''epilepsy/seizures.'' Central nervous system comorbidities were also collapsed into bins for some analyses. The ''psychiatric'' bin included having a diagnosis of one or more of the following: ADHD, anxiety disorder, bipolar disorder, and depression. The ''any'' bin included having a diagnosis of one or more of any of the comorbidities included in this study.
The proportion of patients affected with each comorbidity prior to surgery was calculated. Patients with an un-verified comorbidity were treated as missing values and not included for these calculations. For comparison, general population rates of autism 18 and motor disability 6, 19 were based on pediatric studies, rates of ADHD, 20 anxiety disorder, 20 depression, 20 and migraine 21 were based on children and adolescent studies, and rates of bipolar disorder 22 were based on adolescent studies. The general population rate for cognitive disability [23] [24] [25] was determined by adding the rates for developmental delay, intellectual disability, and learning disabilities in pediatric studies.
Treatment History
Treatment history and surgery outcome information was abstracted from the CCHMC Division of Neurology clinical seizure database. Abstracted variables included total number of trialed antiepileptic drugs, history of tuberous sclerosis complex, whether or not grid placement was performed, frequency of seizures prior to surgery, duration of epilepsy prior to surgery, type of surgery, and completeness of resection. Type of surgery was dichotomized into temporal and extratemporal procedures. Temporal procedures included anterior temporal lobectomy and temporal lobectomy. Extratemporal procedures included corticectomy, extratemporal lobectomy, hemispherotomy, lesionectomy, and multilobar surgery. Completeness of resection was determined by either (1) all of magnetic resonance imaging (MRI) abnormality resected in cases for which no invasive electroencephalography (EEG) performed or (2) both MRI abnormality and seizure onset zone (determined by clinical team as the group of 5 electrodes with consistent earliest ictal change) resected in cases for which invasive EEG performed. 
Surgery Outcomes
Surgery outcome data were reported using the International League Against Epilepsy (ILAE) scale. 26 Outcome data were reported at 1 year postsurgery and the patient's most recent evaluation. Seizure category was defined based on brain MRI and EEG concordance with the operated hemisphere. MRI, Ictal EEG, EEG and MRI/EEG concordance were defined as previously described. 27 Outcome data were collapsed into dichotomous variables. Patients who remained seizure-free after surgery were categorized as ILAE ¼ 1 and patients who were not seizure-free after surgery were categorized as ILAE > 1. Seizure category data were reported as an ordinal variable where 1 (best expected outcome) was defined as lesional or multilesional concordant, 2 was defined as nonlesional concordant, 3 was defined as lesional or multilesional discordant, and 4 (worst expected outcome) was defined as nonlesional discordant.
Statistical Analysis
Univariate analyses were performed to determine if the mean proportion of affected relatives across all patients was significantly greater than what would be expected based on prevalence rates in the general population. Fisher's exact tests were used to compare patient comorbidities to ILAE surgery outcomes and to compare seizure category across ILAE surgery outcomes. T-tests and Wilcoxon rank sum tests were used to compare the mean proportions of affected relatives to ILAE surgery outcomes. Logistic regression models were used to identify predictors of surgery outcome and seizure category. A stepwise variable selection procedure was used to find the most parsimonious model. Results were considered to be statistically significant if the P-values were less than .05. All statistical analyses were performed using SAS ® (version 9.3, SAS Institute Inc, Cary, NC).
Results

Response Rate and Demographics
One hundred fifty-six individuals were contacted to participate in the study. Of these, 8 individuals were excluded due to the inability to provide family history information (n ¼ 6) or the inability to speak English (n ¼ 2). A total of 52 participants completed the questionnaire, a 35.1% response rate. One individual was lost to follow-up regarding seizure outcome and patient comorbidity data. This individual was only included in the analysis of affected family members and demographic information. Mean follow-up time from initial surgery to most recent evaluation was 42.7 months for the entire cohort, with no significant difference between ILAE groups. There was an uneven distribution of males and females, with males making up 41.7% (10/24) of the ILAE ¼ 1 group and 70.4% (19/27) of the ILAE > 1 group (P ¼ .05) ( Table 2 ). Grid placement was more common in the ILAE > 1 group than in the ILAE ¼ 1 group (92.6% [25/27] vs 66.7% [16/24] ; P ¼ .03). Patients in the ILAE > 1 group also had tried a greater number of medications than patients in the ILAE ¼ 1 group (5.04 vs 3.38; P ¼ .04) ( Table 3) . Logistic regression models identified total number of trialed antiepileptic drugs as a predictor of worse outcomes following surgery when it was the only variable included in the model, with the odds of having an ILAE > 1 postsurgery increasing by a factor of 1.3 for every additional medication trialed (OR ¼ 1.3; 95% CIs 1.0, 1.6; AUC ¼ 0.68; P ¼ .04).
Comorbidities in Patients
Patients had significantly higher rates of ADHD (P < .001), autism spectrum disorder (P < .001), cognitive disability (P < .001), and motor disability (P < .001) than the general population (Table 4) .
Comorbidities in Patients' Families
First-degree relatives had significantly higher rates of depression (P < .001) and decreased rates of cognitive disability (P < .001) than the general population (Table 5) . Total relatives had significantly higher rates of depression (P < .001) and epilepsy/seizures (P ¼ .03) and decreased rates of cognitive disability (P < .001) and migraine (P ¼ .005) compared to the general population (Table 5) .
Patient Comorbidities as a Predictor of Surgery Outcome
When examining comorbidities individually, a diagnosis of autism or cognitive disability was significantly associated with an ILAE > 1 ( Cognitive disability was also a predictor of ILAE > 1 outcome in logistic regression models, with the odds of a poor outcome increasing by a factor of 6.2 in patients diagnosed with a cognitive disability prior to surgery (OR ¼ 6.2; 95% CIs 1.6, 31.2; AUC ¼ 0.66; P ¼ .01). In this case the probability of ILAE > 1 outcome given a patient had cognitive disability was 0.65 with a 95% CI of 0.48, 0.78. Similarly, if a patient did not have cognitive disability the probability dropped to 0.23 with a 95% CI of 0.08, 0.52.
There was a significant association between patients affected with any of the examined comorbidities and an ILAE > 1 ( ILAE outcome scores at 12 months postsurgery were available for 44 patients. Twenty-one patients had an ILAE ¼ 1 and 23 patients had an ILAE > 1. When the above analyses were repeated, there were no statistically significant associations between patient comorbidities and ILAE outcome at 12 months postsurgery (data not shown).
Family History of Comorbidities as a Predictor of Surgery Outcome
No significant associations were identified between mean proportion of affected first-degree relatives or total relatives and ILAE outcome. Patients with ILAE > 1 had an increased mean proportion of total relatives affected with seizures/epilepsy (mean ¼ 0.037, SD ¼ 0.064) than patients with ILAE ¼ 1 (mean ¼ 0.012, SD ¼ 0.02), which trended toward significance by t-test (P ¼ .057; data not shown).
Comorbidities as a Predictor of Seizure Category
There was a significant difference in distribution of seizure category across ILAE groups, with more individuals with ''poorer'' (more discordant, MRI nonlesional) seizure category variables having an ILAE > 1 (P ¼ .02) ( Table 3) . Logistic regression models demonstrated an association between the number of trialed antiepileptic drugs and ''poorer'' category, with the odds of having a ''poorer'' seizure category increasing by a factor of 1.4 for every additional medication trialed (OR ¼ 1.4; 95% CIs 1.1, 1.7; AUC ¼ 0.67; P ¼ .006).
Discussion
This study is the first to comprehensively describe relationships between central nervous system comorbidities in intractable epilepsy patients, their families, and resective surgery outcomes. Higher rates of central nervous system comorbidities were identified in both patients and their families when compared to the general population. In addition, the presence of autism or cognitive disability in patients was associated with poorer long-term seizure outcome following resective surgery.
Comorbidities in Patients
Patients had higher rates of ADHD, autism, cognitive disability, and motor disability compared to the general population, as expected based on current literature. Since rates of central nervous system comorbidities in patients with refractory epilepsy are not established, the authors were not able to compare the prevalence rates from their study to matched controls. When considering central nervous system comorbidity rates in the wider epilepsy population, the rates of ADHD 1, 3 in the authors' population fell within the ranges previously reported. However, there were differences in the population's comorbidity rates compared to those reported in the literature, including lower rates of anxiety (2.2% vs 16%), 3 3 and migraine (8.2% vs 20-24%) 3 and higher rates of cognitive and motor disability (74.0% and 42.0%, respectively vs 15-30% 6 for either comorbidity). The lower prevalence rates reported in the current study are partially due to the fact that any comorbidities diagnosed postsurgery were recoded as negative. Multiple individuals in the current cohort went on to be diagnosed with several central nervous system comorbidities, including anxiety, depression, and migraine postsurgery (data not shown). Alternatively, certain comorbidities may be under-diagnosed in children or pediatric patients have not yet developed them. In addition, since the current sample population includes only patients with intractable epilepsy, disease progression or severity may partially account for the higher prevalence of cognitive impairment in this study. 28 Similarly, McClellan et al 5 reported 47% of their pediatric cohort to have a learning disability following temporal lobe surgery for epilepsy, which would represent only a subset of the broadly defined cognitive disability category in the current cohort. < 0.001
Abbreviation: ADHD, attention-deficit/hyperactivity disorder. P-values from exact 1-sided binomial model. Percentages calculated by multiplying the proportion of affected patients by 100. General population rates were reported from the following sources: ADHD, 20 anxiety, 20 autism, 18 bipolar disorder, 22 cognitive disability (including rates for developmental delay, intellectual disability, and learning disability), [23] [24] [25] depression, 20 migraine, 21 motor disability.
6, 19
Comorbidities in Patients' Families
Patients' family members had higher rates of some central nervous system comorbidities compared to the general population. First-degree relatives had increased rates of depression. Total relatives had increased rates of depression and epilepsy/ seizures. However, rates of cognitive disability in first-degree relatives and cognitive disability and migraines in total relatives were significantly lower than the reported general population rates for these conditions. Higher rates of depression have previously been reported in mothers of children with epilepsy. 29, 30 While self-reported data are known to be limited by recall bias, 31 studies have consistently found family history information to have a high specificity, meaning few relatives without disease are misclassified as having disease. 32 Furthermore, previous studies have shown that the sensitivity of reported health information decreases as the degree of relatedness increases. 33 Therefore, the authors suspect that the true prevalence rates of comorbidities in this study are higher than the rates that were reported by participants, particularly for more distant relatives.
Comorbidities and Surgery Outcome
Patients with a diagnosis of autism or cognitive disabilities were more likely to have poor long-term seizure outcomes. In the authors' patient population, patients with poorer seizure outcomes trialed more antiepileptic drugs than patients with better seizure outcomes. Total number of trialed antiepileptic drugs was also a significant predictor of worse surgery outcomes, suggesting that providers were more likely to trial more antiepileptic drugs prior to surgery in patients with a profile less likely to benefit from resective surgery. Number of antiepileptic drugs did not predict the presence of autism or cognitive impairment in the cohort and there was no significant interaction between these terms in logistic regression models (data not shown). Therefore, the current data suggest that antiepileptic drug usage does not contribute to the increased prevalence of autism or cognitive disability in the authors' patient population and should not be considered a confounding factor.
Patients reported to be affected with any comorbidity were also more likely to have poor long-term seizure outcome. Strikingly, all but 1 of the patients unaffected by all of the examined comorbidities remained seizure-free at their most recent evaluation. Taken as a whole, these data imply that patient central nervous system comorbidities, most importantly, the presence of cognitive disability or autism, have negative prognostic value for seizure outcome following resective surgery. Relationships between poorer surgery outcomes and the presence of autism, 5 cognitive dysfunction 14 and lifetime history of psychiatric comorbidities 13 have been reported. This study supports that autism and cognitive disability are predictors of worse surgery outcomes in a pediatric population. However, the authors did not replicate the reported association with individual or pooled psychiatric comorbidities. This discrepancy may be explained via differences in study populations. Kanner et al 13 reported lifetime rates of psychiatric comorbidities in their adult patients, while the current authors report presurgical diagnoses in pediatric patients. It is possible that as the authors' population ages, the rate of psychiatric comorbidities may increase. Finally, an association between the proportion of total relatives with seizures/epilepsy and worse surgery outcomes trended toward significance, supporting the role of detailed family history gathering for prognosis. 34 
Pathophysiological Mechanism of Epilepsy and Central Nervous System Comorbidities
Two possible general hypotheses could be drawn. The first is that certain patients are more likely to have a widely distributed epileptic network that is difficult to completely localize and resect. The second is that patients with a genetic propensity to other brain disorders have localizable epilepsy which is resected completely, but a secondary area of epileptogenesis later develops, preventing long-term seizure freedom.
The relationship between autism, cognitive impairment, and the evolution of seizure outcomes over time supports the latter hypothesis. The fact that initial postoperative outcomes at 1 year were generally favorable in these patients and then deteriorated to significantly poorer outcomes suggests epileptogenesis at another site is responsible for their poor outcomes, rather than incomplete resection of the epileptic network at the time of surgery. Seizures resulting from incomplete resection of the epileptic network are generally present within 6 -12 months of epilepsy surgery. 35, 36 Prognostic factors identified in this study should be used to improve preoperative counseling rather than categorically rule out surgery. For instance, patients with MRI nonlesional and discordant evaluations are generally not good candidates for resective surgery, but in a small number (n ¼ 6 in this series) there may be sufficient evidence for a ''dominant'' resectable epileptogenic zone to palliate seizure frequency and potentially reduce medication burden.
Study Limitations
Although this study was limited to those who chose to participate, the study population was similar to the larger CCHMC epilepsy population in terms of the relative frequency of seizure-free outcome and the distribution between seizure category and outcome. The majority of patients had a histopathological diagnosis of cortical dysplasia as an etiology. While cortical dysplasia is the most common cause of pediatric intractable epilepsy leading to epilepsy surgery, 37 it does limit generalizability to other etiologies. Likewise, findings of increased comorbidities in patients and families were observed in this study of intractable pediatric epilepsy, but may not be generalizable to a larger epilepsy population.
Conclusion
The authors found an increased prevalence of presurgical central nervous system comorbidities in epilepsy patients undergoing resective surgery. Increased prevalence of depression and epilepsy/seizures in other family members is consistent with the current literature. Cognitive disability and autism spectrum disorder in the patient appear to be important negative prognostic factors for postoperative seizure outcome. Identification of such factors and a detailed family history may provide information to better counsel families considering resective surgery. The findings support the hypothesis of a common pathophysiological mechanism between epilepsy and its comorbidities and highlight the importance of these comorbidities in both the patient and other relatives.
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